Garrett E R, Gürkan T
J Pharm Sci. 1980 Oct;69(10):1116-34. doi: 10.1002/jps.2600691002.
The pharmacokinetics of intravenously administered heroin and its derived metabolites, 6-O-monoacetylmorphine, morphine, and the glucuronidated conjugates of morphine, were studied in dogs at doses of 0.1-0.5 mg/kg. The spontaneous hydrolysis of the sampled biological fluids was inhibited by tetraethyl pyrophosphate so that the heroin concentration at the times of sampling could be analyzed for the first time. Heroin is concomitantly rapidly metabolized and distributed among body tissues. Metabolic clearance of 2916 +/- 321 ml/min are largely extrahepatic and are sixfold greater than hepatic blood flow. Nevertheless, the terminal half-life of 60-90 min resembles that of morphine and is maintained by the rate-determining return of distributed heroin from esterase-free tissues. Normal renal clearances of 43 +/- 6 ml/min result in 1.6 +/- 0.2% of the dose being renally excreted unchanged. The large overall volume of distribution, 344 +/- 60 liters, is indicative of heroin's wide distribution and lipophilicity, which rapidly equilibrates heroin in the plasma with the cerebrospinal fluid. Heroin is concomitantly metabolized almost equally to 6-O-monoacetylmorphine and morphine. The monoacetylmorphine is metabolized concomitantly to morphine and glucuronide conjugates in a 4:3 ratio and exercises its own activity. Its time course is close to that of heroin, although the total clearance (2200 ml/min) and overall volumes of distribution (90-170 liters) were less. The integrated model of transformations and eliminations was constructed with concomitant metabolism of the heroin metabolite, 6-O-monoacetylmorphine, to morphine and glucuronide conjugates. The assumption that the glucuronide conjugates partition into the bile and systemic circulation in the same ratio as does the conjugate of the derived morphine metabolite gave pharmacokinetic parameters consistent with the morphine pharmacokinetics studied previously and provided excellent fits of the plasma level-time curves of all of the derived metabolites of heroin.
研究了静脉注射海洛因及其代谢产物6 - O - 单乙酰吗啡、吗啡以及吗啡的葡萄糖醛酸结合物在犬体内的药代动力学,给药剂量为0.1 - 0.5mg/kg。用焦磷酸四乙酯抑制采集的生物流体的自发水解,从而首次能够分析采样时的海洛因浓度。海洛因在体内迅速代谢并分布于身体组织中。代谢清除率为2916±321ml/min,主要发生在肝外,比肝血流量高6倍。然而,60 - 90分钟的终末半衰期与吗啡相似,且由分布在无酯酶组织中的海洛因以限速方式返回维持。正常肾清除率为43±6ml/min,导致1.6±0.2%的剂量以原形经肾排泄。总体分布容积大,为344±60升,表明海洛因分布广泛且具有亲脂性,能使血浆中的海洛因与脑脊液迅速达到平衡。海洛因几乎等量地代谢为6 - O - 单乙酰吗啡和吗啡。单乙酰吗啡以4:3的比例同时代谢为吗啡和葡萄糖醛酸结合物,并发挥自身活性。其时间过程与海洛因相近,尽管总清除率(2200ml/min)和总体分布容积(90 - 170升)较小。构建了转化和消除的综合模型,其中海洛因代谢产物6 - O - 单乙酰吗啡同时代谢为吗啡和葡萄糖醛酸结合物。假设葡萄糖醛酸结合物以与衍生吗啡代谢产物的结合物相同的比例分配到胆汁和体循环中,得到的药代动力学参数与先前研究的吗啡药代动力学一致,并能很好地拟合海洛因所有衍生代谢产物的血浆浓度 - 时间曲线。